Ally Bridge, LifeTech and Quantum Surgical form JV in China for treating liver cancer.

Global Banking News-April 4, 2019-Ally Bridge, LifeTech and Quantum Surgical form JV in China for treating liver cancer

(C)2019 ENPublishing - http://www.enpublishing.co.uk

Life science investment firm Ally Bridge Group (ABG) stated on Wednesday that it plans to form a three-way joint venture (JV) in China through agreements with LifeTech Scientific Corporation (SEHK:1302), a medical device company in China, and French surgical robotics company Quantum Surgical.

The newly formed JV will focus on the R&D and commercialisation of Quantum Surgical's integrated surgical robot platform in China for interventional oncology, with the first target indication being liver cancer. China represents more than 50% of the world's incidence of liver cancer.

ABG made a Series A investment in Quantum Surgical in 2018, in which LifeTech also participated through its existing partnership with ABG. ABG initiated and led the design and formation of the JV, where LifeTech is the majority...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT